5th Annual Conference of Asia-Oceania Particle Therapy Co-Operative Group (PTCOG-AO 2025)
07 November - 09 November, 2025, Hong Kong
A single-institution retrospective study comparing proton therapy with conventional radiotherapy using tomotherapy or volumetric modulated arc therapy demonstrated low toxicity and significant dosimetric advantage with proton therapy in Chinese breast cancer patients following definitive surgery, according to data presented at APTCOG-AO 2025 conference held in Hong Kong.
